Literature DB >> 10782835

Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen.

K C Lin1, H Y Lin, P Chou.   

Abstract

OBJECTIVE: This is a population survey conducted in 1991-92 among residents aged > or =30 years in Kin-Hu, Kinmen, with a 77.7% response rate to study the prevalence of hyperuricemia and hyperuricemia associated gout. A stratified analysis based on sex and age was used to assess the interaction and analyze the associated risk factors for hyperuricemia and gout.
METHODS: Hyperuricemia was defined as uric acid > or =7.0 mg/dl for men and > or =6.0 mg/dl for women. Gout was clinically diagnosed by a senior rheumatologist based on patient's history and examination according to the clinical criteria of Wallace. Basic demographic and lifestyle variables as well as biochemical data were collected.
RESULTS: The prevalence of hyperuricemia was 25.8% (391/1515) in men and 15.0% (250/1670) in women. The prevalence of gout among hyperuricemic subjects was 11.5% for men and 3% for women. According to age spectrum, the risk factor for hyperuricemia was hyperlipidemia in young adults (30-39 yrs); lifestyle and some clinical syndromes played a significant role in middle aged persons (40-59 yrs). The different risk factors between the sexes in middle age were alcohol consumption effect in men and menopause effect in women. Impaired renal function and use of diuretics became the important factors in the elderly (> or =60 yrs). The risk factors for gout among either the general population or subjects with hyperuricemia were concentration of serum uric acid, alcohol consumption, and central obesity.
CONCLUSION: Risk factors for hyperuricemia tended to be different with respect to sex and age. Alcohol consumption and central obesity were independent predictors of gout among hyperuricemic subjects irrespective of uric acid level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782835

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  50 in total

Review 1.  Pathogenesis of hyperuricemia: recent advances.

Authors:  Manisha Ghei; Mihaela Mihailescu; Dennis Levinson
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

Review 2.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

3.  Manifestations of metabolic syndrome associated with male gout in different age strata.

Authors:  Shih-Yang Chen; Ching-Lang Chen; Ming-Lai Shen
Journal:  Clin Rheumatol       Date:  2007-01-26       Impact factor: 2.980

Review 4.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

5.  Association of incident gout and mortality in dialysis patients.

Authors:  Scott D Cohen; Paul L Kimmel; Robert Neff; Lawrence Agodoa; Kevin C Abbott
Journal:  J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 10.121

Review 6.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

Review 7.  Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.

Authors:  Chun Hu; Xiaoyan Wu
Journal:  Int Urol Nephrol       Date:  2019-08-28       Impact factor: 2.370

8.  Longevity-associated NADH dehydrogenase subunit-2 237 Leu/Met polymorphism influences the effects of alcohol consumption on serum uric acid levels in nonobese Japanese men.

Authors:  Akatsuki Kokaze; Mamoru Ishikawa; Naomi Matsunaga; Masao Yoshida; Masao Satoh; Koji Teruya; Rie Honmyo; Misako Yorimitsu; Yumi Masuda; Yoshiko Uchida; Yutaka Takashima
Journal:  J Hum Genet       Date:  2006-08-08       Impact factor: 3.172

Review 9.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.